Last updated on July 20, 2026
To put you at ease, no – surgery is not always necessary for Peyronie’s disease, and for many men, it is not even the first treatment discussed.
A common misconception is that once Peyronie’s disease is diagnosed, surgery becomes inevitable. Treatment decisions are far more nuanced. Symptom severity, disease stage, erectile function and the practical impact on sexual activity all influence the treatment pathway.
Some men have mild curvature that remains stable for years and causes little functional difficulty. Others develop more complex deformities that interfere with penetrative intercourse, erection stability or both.
Curvature alone rarely determines treatment.
A penis with a moderate bend may remain functional, while a smaller deformity with narrowing, instability or erectile dysfunction can cause far greater difficulty.
Surgery Is Not Necessary in Every Case of Peyronie’s Disease
Surgery is generally reserved for men whose symptoms significantly affect function or quality of life once the condition has stabilised, particularly when conservative or non-surgical management is unlikely to provide sufficient improvement or has not achieved the desired outcome.
Peyronie’s disease is usually considered in two phases.
Active phase
Curvature, plaque formation, pain or deformity may still be changing. This phase often lasts around 12 to 18 months, although the duration varies between individuals.
Stable phase
Symptoms have become more consistent, with little recent structural change.
Most surgeons will only consider surgery once the deformity is stable. Operating while plaque and curvature are still evolving makes long-term outcomes harder to predict.
Not every patient seen by a specialist is a surgical candidate.
A man with a mild 20-degree curve, good erections and no difficulty during intercourse may not need surgery at all.
A man with severe angulation, loss of penetration or significant structural instability requires a very different discussion.
Treatment decisions are based on function, not just appearance.
Treatment Decisions Depend on More Than Curvature Alone
Peyronie’s disease presents differently from one man to the next.
Two men with similar curvature can have very different symptoms.
Common Symptoms
Peyronie’s disease may involve:
- Penile curvature
- Palpable plaque or scar tissue
- Penile shortening
- Narrowing
- Hourglass deformity
- Pain during erection
- Erectile dysfunction
- Reduced rigidity in part of the shaft
Many men focus heavily on the angle of curvature. In practice, curvature is only one part of assessment.
Why Curvature Angle Can Be Misleading
Curvature angle does not always reflect severity.
A 30-degree bend may remain manageable during intercourse.
A 20-degree curve combined with narrowing or hourglass deformity may cause major functional problems.
Some men develop what is often called a hinge effect. One section of the shaft loses structural support during erection and buckles under pressure.
Penetration can become difficult even when the visible curve looks modest.
When Symptoms Become Functionally Significant
Treatment discussions usually become more relevant when symptoms begin affecting:
- Penetrative intercourse
- Erection stability
- Comfort during sex
- Sexual confidence
- Overall quality of life
Functional impact usually carries more weight than appearance alone.
Multi-Modal Treatment May Be Appropriate for Some Men
Some men may be suitable for non-surgical management following specialist assessment.
Non-surgical management is rarely about a single intervention.
In clinical practice, some patients may be considered for multi-modal treatment. This involves using several complementary treatment approaches within a personalised treatment plan rather than relying on one therapy alone.
The aim is to tailor management around the individual deformity, symptoms and stage of disease.
Examples of therapies that may form part of a multi-modal treatment strategy include:
These therapies may be considered where clinically appropriate as part of broader treatment planning.
They are not suitable for every patient and should not be viewed as a guaranteed alternative to surgery.
Suitability is determined during specialist assessment rather than by curvature alone. Factors that may influence whether a particular treatment is appropriate include:
- whether the disease is in the active or stable phase
- the size and location of the plaque
- the severity and type of deformity
- erectile function
- patient symptoms, priorities and treatment goals
Our guide to Peyronie’s treatment options explains these approaches in more detail.
If you are comparing pathways, understanding any Peyronie’s treatment cost may also help when considering practical next steps.
Early Assessment May Preserve More Treatment Choices
Early specialist assessment can help establish what stage the condition is in and how it is progressing.
This does not guarantee better outcomes or remove the possibility of surgery.
It does provide clearer clinical context.
During the active phase, specialists often monitor:
- Progression of curvature
- Plaque development
- Pain changes
- Erectile function
- Structural instability
This helps build a clearer picture of disease behaviour.
Two patients may present very differently.
One seeks assessment soon after noticing pain and new curvature. Progression is documented early and future treatment discussions begin with a clear baseline.
Another presents years later after shortening, narrowing and intercourse difficulty have become established.
The eventual treatment pathway depends on many variables, but delayed presentation often leaves less historical context to work with.
Surgery Can Help in Selected Cases, But Requires Careful Planning
Surgery can be highly appropriate in selected cases, but it requires careful patient selection and realistic expectations.
The decision is based on more than deformity.
Erectile function, plaque complexity, shortening and treatment goals all influence surgical planning.
Common Surgical Approaches
Different procedures are used depending on the clinical situation of the patient.
Plication or Nesbit-type procedures
These straighten the curvature by shortening the longer side of the penis. They are commonly used when erectile function is preserved. Penile shortening can occur.
Plaque incision or grafting procedures
These may be considered in more complex deformities, particularly when shortening, indentation or severe angulation are present. In selected cases, grafting may help address deformity while preserving length, though erectile changes remain a recognised risk.
Penile prosthesis surgery
This may be considered when significant erectile dysfunction exists alongside Peyronie’s disease.
Recovery and Expectations
Surgical discussions usually include:
- Recovery time
- Possible shortening
- Erectile changes
- Sensation changes
- Residual deformity
The goal is not a perfect anatomical result. The goal is functional improvement with realistic expectations.
Specialist Assessment Helps Identify the Most Appropriate Pathway
The most appropriate treatment can only be recommended after understanding symptoms, disease stage and treatment goals.
Assessment typically includes:
- Symptom history
- Physical examination
- Plaque assessment
- Deformity evaluation
- Erectile function review
- Discussion of treatment priorities
The consultation is not simply about deciding whether surgery is needed.
It is about identifying the management pathway most appropriate for the individual patient.
Surgery is not always necessary for Peyronie’s disease.
Some men never require surgery. Others reach a stage where surgery becomes the most appropriate option because deformity significantly affects function.
Treatment decisions depend on far more than curvature alone. Disease stage, deformity pattern, erectile function and sexual goals all shape the treatment pathway.
If you are unsure whether surgery or a non-surgical approach may be appropriate for your situation, a specialist assessment can help clarify the options available. If you would like further guidance, you can contact us to discuss your symptoms confidentially.
Written By:
Charles Turner
Charles Turner is a seasoned Management Consultant with associations with a range of international medical companies including GlaxoSmithKline and Bristol Myers Squibb.
He is responsible for the operational, strategic, and clinical excellence of MansMatters as well as the Peyronie’s disease research and development programmes.
Reviewed by:
Mr. Leon Alamshan
A graduate of St. George’s Medical School, he has developed innovative treatment protocols that have supported improved quality of life for 1000’s of patients worldwide.
